Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs

Cancer remains a heavy health burden resulting in a high rate of mortality around the world. The presently used anticancer drugs suffer from several shortcomings, such as drug toxicity, poor biodegradability and bioavailability, and poor water solubility and drug resistance. Cancer is treated effect...

Full description

Bibliographic Details
Main Authors: Sibusiso Alven, Blessing Atim Aderibigbe
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/10/8/1556
_version_ 1797559570400280576
author Sibusiso Alven
Blessing Atim Aderibigbe
author_facet Sibusiso Alven
Blessing Atim Aderibigbe
author_sort Sibusiso Alven
collection DOAJ
description Cancer remains a heavy health burden resulting in a high rate of mortality around the world. The presently used anticancer drugs suffer from several shortcomings, such as drug toxicity, poor biodegradability and bioavailability, and poor water solubility and drug resistance. Cancer is treated effectively by combination therapy whereby two or more anticancer drugs are employed. Most of the combination chemotherapies result in a synergistic effect and overcome drug resistance. Furthermore, the design of polymer-based nanocarriers for combination therapy has been reported by several researchers to result in promising therapeutic outcomes in cancer treatment. Curcumin exhibits good anticancer activity but its poor bioavailability has resulted in its incorporation into several polymer-based nanocarriers resulting in good biological outcomes. Furthermore, the incorporation of curcumin together with other anticancer drugs have been reported to result in excellent therapeutic outcomes in vivo and in vitro. Due to the potential of polymer-based nanocarriers, this review article will be focused on the design of polymer-based nanocarriers loaded with curcumin together with other anticancer drugs.
first_indexed 2024-03-10T17:47:14Z
format Article
id doaj.art-c509e4dd467c4d58a52716aad1a65522
institution Directory Open Access Journal
issn 2079-4991
language English
last_indexed 2024-03-10T17:47:14Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Nanomaterials
spelling doaj.art-c509e4dd467c4d58a52716aad1a655222023-11-20T09:29:59ZengMDPI AGNanomaterials2079-49912020-08-01108155610.3390/nano10081556Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer DrugsSibusiso Alven0Blessing Atim Aderibigbe1Department of Chemistry, University of Fort Hare, Alice Eastern Cape 5700, South AfricaDepartment of Chemistry, University of Fort Hare, Alice Eastern Cape 5700, South AfricaCancer remains a heavy health burden resulting in a high rate of mortality around the world. The presently used anticancer drugs suffer from several shortcomings, such as drug toxicity, poor biodegradability and bioavailability, and poor water solubility and drug resistance. Cancer is treated effectively by combination therapy whereby two or more anticancer drugs are employed. Most of the combination chemotherapies result in a synergistic effect and overcome drug resistance. Furthermore, the design of polymer-based nanocarriers for combination therapy has been reported by several researchers to result in promising therapeutic outcomes in cancer treatment. Curcumin exhibits good anticancer activity but its poor bioavailability has resulted in its incorporation into several polymer-based nanocarriers resulting in good biological outcomes. Furthermore, the incorporation of curcumin together with other anticancer drugs have been reported to result in excellent therapeutic outcomes in vivo and in vitro. Due to the potential of polymer-based nanocarriers, this review article will be focused on the design of polymer-based nanocarriers loaded with curcumin together with other anticancer drugs.https://www.mdpi.com/2079-4991/10/8/1556canceranticancer drugscurcumincombination therapypolymer-based nanocarriers
spellingShingle Sibusiso Alven
Blessing Atim Aderibigbe
Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs
Nanomaterials
cancer
anticancer drugs
curcumin
combination therapy
polymer-based nanocarriers
title Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs
title_full Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs
title_fullStr Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs
title_full_unstemmed Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs
title_short Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs
title_sort efficacy of polymer based nanocarriers for co delivery of curcumin and selected anticancer drugs
topic cancer
anticancer drugs
curcumin
combination therapy
polymer-based nanocarriers
url https://www.mdpi.com/2079-4991/10/8/1556
work_keys_str_mv AT sibusisoalven efficacyofpolymerbasednanocarriersforcodeliveryofcurcuminandselectedanticancerdrugs
AT blessingatimaderibigbe efficacyofpolymerbasednanocarriersforcodeliveryofcurcuminandselectedanticancerdrugs